drug · small molecule
patient view →ondansetron hydrochloride CR
Marketedupdated 2mo agoby $RDHL RedHill Biopharma Ltd.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 1 investigational indication.
targets
5-hydroxytryptamine receptor 3A
all catalysts(77)
approval · 77
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that